Interleukin IL-17A inhibitor (UCB Pharma)

N/A

Report date: 2025/01/26 19:16:08
NME

Base Information

Drug NameInterleukin IL-17A inhibitor (UCB Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin 17A inhibitors
TargetsInterleukin 17A
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUcb Pharma Sa
China Registration ClassN/A

Develop Information

Active CompaniesUcb Pharma Sa
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A